Acceptance and Commitment Therapy and Exercise for Older Adults With Chronic Pain
Launched by THE UNIVERSITY OF HONG KONG · Aug 31, 2022
Trial Information
Current as of May 16, 2025
Unknown status
Keywords
ClinConnect Summary
Chronic pain is classified as persistent or recurrent pain for more than 3 months associated with physical disability, depression and poor psychosocial functioning among older adults; causing a dependence on medication and decreasing their quality of life. There are various treatment options from chronic pain, but the benefits on pain outcomes are minimal and rather short term. Psychological interventions, such as acceptance and commitment therapy (ACT), have shown positive effect on older adults with chronic pain. Using the three core elements of psychological flexibility, older adults are...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age 60 years or above; and
- • have depressive symptoms of mild level or above (PHQ \> 5)
- • have chronic pain (\>3 months)
- • able to give informed consent to participate
- Exclusion Criteria:
- • known history of autism, intellectual disability, schizophrenia-spectrum disorder, bipolar disorder, Parkinson's disease, or dementia
- • (temporary exclusion criteria) imminent suicidal risk difficulty in communication
- • have had stroke, fracture, cardiovascular disease, cardiovascular surgery, artery disease, surgery on vertebrae, and knee replacement in the past 6 months
- • physical activity prohibited by a medical professional
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Terry Y.S. Lum, PhD
Principal Investigator
Department of Social Work and Social Administration, The University of Hong Kong
Gloria Wong, PhD
Principal Investigator
Department of Social Work and Social Administration, The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials